A Real-World Study Investigating Maintenance Rituximab after First Line Induction Therapy in Patients with Follicular Lymphoma treated at the Veterans Health Administration (VHA)
Phase of Trial: Phase IV
Latest Information Update: 27 Dec 2017
At a glance
- Drugs Rituximab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 27 Dec 2017 New trial record
- 12 Dec 2017 According to results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology, the end date of study observation period is 31 Dec 2016.
- 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.